Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95
Open Access
- 24 December 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (4) , 4399-4413
Abstract
Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95 Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95Keywords
This publication has 66 references indexed in Scilit:
- Functional Polymorphisms in FAS/FASL System Increase the Risk of Neuroblastoma in Chinese PopulationPLOS ONE, 2013
- Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunctionProceedings of the National Academy of Sciences, 2010
- Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic EffectThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species–Dependent Signaling PathwayCancer Research, 2010
- mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1Molecular Cell, 2010
- Involvement of FLIP in 2-Methoxyestradiol–Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate ModelClinical Cancer Research, 2009
- Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signalingOncogene, 2007
- Association between FAS polymorphism and prostate cancer developmentProstate Cancer and Prostatic Diseases, 2007
- Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cellsJournal of Cellular Biochemistry, 2004
- Identification of Two Fas-Associated Phosphatase-1 (FAP-1) Promoters in Human Cancer CellsDNA Sequence, 2001